

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.74914509 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.74914509 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.50776361 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32332862 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24391164 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17664674 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14232684 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14232684 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.14232684 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14232684 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.14232684 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14232684 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.10609218 |
| 14 | response to peptidoglycan (GO:0032494) | 3.98714740 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95840401 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.94663990 |
| 17 | detection of bacterium (GO:0016045) | 3.71475896 |
| 18 | detection of other organism (GO:0098543) | 3.67391232 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.65071094 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 3.54336557 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.48209016 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.36899856 |
| 23 | leukocyte aggregation (GO:0070486) | 3.33204737 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.23610364 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.14395716 |
| 26 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.13054889 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.07298206 |
| 28 | barbed-end actin filament capping (GO:0051016) | 3.00654452 |
| 29 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00569054 |
| 30 | neutrophil activation (GO:0042119) | 3.00247935 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.00205625 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 2.98985503 |
| 33 | cellular response to type I interferon (GO:0071357) | 2.97357254 |
| 34 | type I interferon signaling pathway (GO:0060337) | 2.97357254 |
| 35 | granulocyte activation (GO:0036230) | 2.96290813 |
| 36 | detection of external biotic stimulus (GO:0098581) | 2.96216727 |
| 37 | response to type I interferon (GO:0034340) | 2.94861154 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90724638 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89489156 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.87843231 |
| 41 | amino sugar catabolic process (GO:0046348) | 2.86453184 |
| 42 | response to host immune response (GO:0052572) | 2.84044197 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.84044197 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83378992 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82718310 |
| 46 | germinal center formation (GO:0002467) | 2.80659109 |
| 47 | modulation by symbiont of host cellular process (GO:0044068) | 2.80046398 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.78789293 |
| 49 | modulation by virus of host process (GO:0019054) | 2.76611909 |
| 50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74627953 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74526328 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73816161 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73670156 |
| 54 | myeloid dendritic cell differentiation (GO:0043011) | 2.72208636 |
| 55 | negative regulation of innate immune response (GO:0045824) | 2.72102447 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70763364 |
| 57 | response to host (GO:0075136) | 2.70763364 |
| 58 | response to host defenses (GO:0052200) | 2.70763364 |
| 59 | mannose metabolic process (GO:0006013) | 2.70226480 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 2.70057118 |
| 61 | tolerance induction (GO:0002507) | 2.69783309 |
| 62 | positive thymic T cell selection (GO:0045059) | 2.69536300 |
| 63 | respiratory burst (GO:0045730) | 2.68804316 |
| 64 | regulation of necrotic cell death (GO:0010939) | 2.62919261 |
| 65 | regulation of superoxide anion generation (GO:0032928) | 2.62659992 |
| 66 | defense response to protozoan (GO:0042832) | 2.61795845 |
| 67 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60845568 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60122632 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59929306 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 2.56512384 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56298492 |
| 72 | pinocytosis (GO:0006907) | 2.56112542 |
| 73 | myeloid dendritic cell activation (GO:0001773) | 2.55032282 |
| 74 | pyrimidine nucleoside salvage (GO:0043097) | 2.53311652 |
| 75 | pyrimidine-containing compound salvage (GO:0008655) | 2.53311652 |
| 76 | B cell mediated immunity (GO:0019724) | 2.52696527 |
| 77 | N-acetylneuraminate metabolic process (GO:0006054) | 2.52448360 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51300018 |
| 79 | detection of biotic stimulus (GO:0009595) | 2.50935235 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 2.50583608 |
| 81 | response to protozoan (GO:0001562) | 2.48922870 |
| 82 | response to interleukin-15 (GO:0070672) | 2.48785486 |
| 83 | thymic T cell selection (GO:0045061) | 2.47587501 |
| 84 | cellular extravasation (GO:0045123) | 2.47545244 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47530410 |
| 86 | negative regulation of interleukin-6 production (GO:0032715) | 2.47397658 |
| 87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47221533 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.44067802 |
| 89 | regulation of regulated secretory pathway (GO:1903305) | 2.43515405 |
| 90 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.42970858 |
| 91 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42542163 |
| 92 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.41972191 |
| 93 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40269585 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 2.38712137 |
| 95 | regulation of podosome assembly (GO:0071801) | 2.37729484 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.37241305 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.36311514 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.35413657 |
| 99 | regulation of tumor necrosis factor production (GO:0032680) | 2.34770705 |
| 100 | T cell selection (GO:0045058) | 2.34287977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13763077 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99378373 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.76788301 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.75289749 |
| 5 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.52128265 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 2.39745802 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33730141 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28373929 |
| 9 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.26706759 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26208850 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18749096 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18633133 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.12498002 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10462653 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04663470 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.03965635 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02347114 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.97468171 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95399960 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 1.94935553 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92438400 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92067955 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88187628 |
| 24 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.83387080 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83329826 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82372798 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82190832 |
| 28 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.79294432 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78762977 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74602630 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.72004616 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69195668 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67318861 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66870453 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66645022 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64814196 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61703340 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59012737 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57548383 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56073286 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55371591 |
| 42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53424856 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50040356 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49551382 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.48661072 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46792749 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45997578 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44254378 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42144366 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41814380 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41125659 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40362251 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40001699 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39266124 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39023385 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37277027 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37009775 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36042026 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34604490 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32808833 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32563894 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32229022 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31420091 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30779704 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29687727 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28842639 |
| 67 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28223921 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25110346 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25075076 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24596074 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24459578 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24150694 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24130947 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.22655131 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.20683168 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18911022 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17786179 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16150852 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15786090 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15379909 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14719130 |
| 82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13578309 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13492858 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12858534 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12041337 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11449484 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10567373 |
| 88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09611901 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09319894 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09007561 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08162072 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07832491 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05879542 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05730054 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05452913 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04358071 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03266886 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02508520 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01472862 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00504520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.62167915 |
| 2 | MP0003303_peritoneal_inflammation | 3.42522413 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.07190202 |
| 4 | MP0003724_increased_susceptibility_to | 2.75867889 |
| 5 | MP0005451_abnormal_body_composition | 2.75194159 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.62949146 |
| 7 | MP0002419_abnormal_innate_immunity | 2.46847545 |
| 8 | MP0005025_abnormal_response_to | 2.41997356 |
| 9 | MP0000685_abnormal_immune_system | 2.39516617 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.39314170 |
| 11 | MP0005387_immune_system_phenotype | 2.37939983 |
| 12 | MP0001790_abnormal_immune_system | 2.37939983 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.35535593 |
| 14 | MP0005671_abnormal_response_to | 2.34005958 |
| 15 | MP0009840_abnormal_foam_cell | 2.30807261 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.27283650 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.26952663 |
| 18 | MP0004510_myositis | 2.25105543 |
| 19 | MP0006082_CNS_inflammation | 2.23665514 |
| 20 | MP0009785_altered_susceptibility_to | 2.16954704 |
| 21 | MP0001800_abnormal_humoral_immune | 2.09066623 |
| 22 | MP0008260_abnormal_autophagy | 2.08874068 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.04970642 |
| 24 | MP0002723_abnormal_immune_serum | 2.04871874 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.98537825 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.95775952 |
| 27 | MP0001819_abnormal_immune_cell | 1.94667981 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.92456745 |
| 29 | MP0004947_skin_inflammation | 1.91600138 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.90683019 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.87226095 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.86553346 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.84550473 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.81707677 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.81707677 |
| 36 | MP0009278_abnormal_bone_marrow | 1.77410305 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.60855472 |
| 38 | MP0003075_altered_response_to | 1.57149446 |
| 39 | MP0002405_respiratory_system_inflammati | 1.54017186 |
| 40 | MP0000858_altered_metastatic_potential | 1.52388228 |
| 41 | MP0000716_abnormal_immune_system | 1.47975671 |
| 42 | MP0002398_abnormal_bone_marrow | 1.47207023 |
| 43 | MP0001853_heart_inflammation | 1.46847469 |
| 44 | MP0001873_stomach_inflammation | 1.44567689 |
| 45 | MP0000343_altered_response_to | 1.43439727 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.42703944 |
| 47 | MP0004858_abnormal_nervous_system | 1.42307694 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.42050652 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.40442464 |
| 50 | MP0008469_abnormal_protein_level | 1.39429913 |
| 51 | MP0003866_abnormal_defecation | 1.38360113 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.36230632 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.31876873 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.28427917 |
| 55 | MP0002429_abnormal_blood_cell | 1.25831962 |
| 56 | MP0002722_abnormal_immune_system | 1.24179420 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.22979868 |
| 58 | MP0003828_pulmonary_edema | 1.22368631 |
| 59 | MP0009764_decreased_sensitivity_to | 1.21265024 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.20423655 |
| 61 | MP0005310_abnormal_salivary_gland | 1.19272178 |
| 62 | MP0000604_amyloidosis | 1.15410519 |
| 63 | MP0005083_abnormal_biliary_tract | 1.14561386 |
| 64 | MP0005166_decreased_susceptibility_to | 1.13471987 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.11454082 |
| 66 | MP0000490_abnormal_crypts_of | 1.11162138 |
| 67 | MP0008004_abnormal_stomach_pH | 1.07067098 |
| 68 | MP0002933_joint_inflammation | 1.02284487 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.02161116 |
| 70 | MP0001663_abnormal_digestive_system | 1.01163583 |
| 71 | MP0002132_abnormal_respiratory_system | 0.97640726 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.97003466 |
| 73 | MP0001851_eye_inflammation | 0.91858199 |
| 74 | MP0005375_adipose_tissue_phenotype | 0.87094753 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.85888361 |
| 76 | MP0005390_skeleton_phenotype | 0.85385230 |
| 77 | MP0000750_abnormal_muscle_regeneration | 0.85168390 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.85077962 |
| 79 | MP0004883_abnormal_blood_vessel | 0.83776707 |
| 80 | MP0001849_ear_inflammation | 0.80115872 |
| 81 | MP0005164_abnormal_response_to | 0.79966792 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 0.79732666 |
| 83 | MP0003448_altered_tumor_morphology | 0.78320141 |
| 84 | MP0004381_abnormal_hair_follicle | 0.77992648 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.77877123 |
| 86 | MP0000249_abnormal_blood_vessel | 0.77663325 |
| 87 | MP0003795_abnormal_bone_structure | 0.77452930 |
| 88 | MP0003279_aneurysm | 0.76756161 |
| 89 | MP0005165_increased_susceptibility_to | 0.76604119 |
| 90 | MP0005365_abnormal_bile_salt | 0.75321491 |
| 91 | MP0004130_abnormal_muscle_cell | 0.75233869 |
| 92 | MP0002796_impaired_skin_barrier | 0.75172722 |
| 93 | MP0008874_decreased_physiological_sensi | 0.75110432 |
| 94 | MP0009763_increased_sensitivity_to | 0.72985221 |
| 95 | MP0000747_muscle_weakness | 0.72766227 |
| 96 | MP0000609_abnormal_liver_physiology | 0.70755809 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.70366997 |
| 98 | MP0003646_muscle_fatigue | 0.69596662 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.69416632 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.69023972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.73326928 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.26470512 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.12086520 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.95773738 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89068047 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89068047 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89068047 |
| 8 | Myositis (HP:0100614) | 3.61163085 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43647949 |
| 10 | Petechiae (HP:0000967) | 3.25973560 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20179106 |
| 12 | Obstructive lung disease (HP:0006536) | 3.20179106 |
| 13 | Orchitis (HP:0100796) | 3.11498725 |
| 14 | Purpura (HP:0000979) | 3.06514720 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.05186967 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.04022658 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03848657 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 2.98332839 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 2.96532552 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 2.91905231 |
| 21 | Increased IgE level (HP:0003212) | 2.90160528 |
| 22 | Cellulitis (HP:0100658) | 2.89882700 |
| 23 | Loss of speech (HP:0002371) | 2.77669203 |
| 24 | Stomatitis (HP:0010280) | 2.72373453 |
| 25 | Meningitis (HP:0001287) | 2.71578165 |
| 26 | Prolonged bleeding time (HP:0003010) | 2.66425552 |
| 27 | Increased serum ferritin (HP:0003281) | 2.63530487 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.63420392 |
| 29 | Hepatosplenomegaly (HP:0001433) | 2.62473644 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61494798 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.61378108 |
| 32 | Vasculitis (HP:0002633) | 2.59555544 |
| 33 | Amyloidosis (HP:0011034) | 2.56099340 |
| 34 | Disinhibition (HP:0000734) | 2.55837906 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.55239269 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.53346955 |
| 37 | Optic neuritis (HP:0100653) | 2.53346955 |
| 38 | Recurrent skin infections (HP:0001581) | 2.48834413 |
| 39 | Axonal loss (HP:0003447) | 2.46842804 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.44790215 |
| 41 | Gingivitis (HP:0000230) | 2.41108881 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.40691546 |
| 43 | Myopathic facies (HP:0002058) | 2.40158084 |
| 44 | Urticaria (HP:0001025) | 2.35880601 |
| 45 | Personality changes (HP:0000751) | 2.34071194 |
| 46 | Colitis (HP:0002583) | 2.31940897 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.31771699 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.31589507 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.28580896 |
| 50 | Epistaxis (HP:0000421) | 2.28231531 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.26690933 |
| 52 | Increased connective tissue (HP:0009025) | 2.26550325 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.24871560 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22404590 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22404590 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22404590 |
| 57 | Abnormality of iron homeostasis (HP:0011031) | 2.20699974 |
| 58 | Pustule (HP:0200039) | 2.19577688 |
| 59 | Recurrent viral infections (HP:0004429) | 2.17109142 |
| 60 | Progressive neurologic deterioration (HP:0002344) | 2.16447887 |
| 61 | Hypertensive crisis (HP:0100735) | 2.12968719 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.08250453 |
| 63 | Hypertriglyceridemia (HP:0002155) | 2.06885174 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06421314 |
| 65 | Exercise-induced myalgia (HP:0003738) | 2.06346847 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.05312264 |
| 67 | Encephalitis (HP:0002383) | 2.04886792 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.04362737 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04362737 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.02547917 |
| 71 | Bulbar palsy (HP:0001283) | 2.01854452 |
| 72 | Asymmetric septal hypertrophy (HP:0001670) | 2.00757539 |
| 73 | Malnutrition (HP:0004395) | 2.00579704 |
| 74 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99269793 |
| 75 | Nasal polyposis (HP:0100582) | 1.99131769 |
| 76 | Polycythemia (HP:0001901) | 1.98919950 |
| 77 | Chest pain (HP:0100749) | 1.97227350 |
| 78 | Acute hepatic failure (HP:0006554) | 1.95506232 |
| 79 | Pulmonary infiltrates (HP:0002113) | 1.94149553 |
| 80 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92312076 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92312076 |
| 82 | Increased IgM level (HP:0003496) | 1.89842709 |
| 83 | Stridor (HP:0010307) | 1.89796080 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 1.88451106 |
| 85 | Easy fatigability (HP:0003388) | 1.88253560 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.87999712 |
| 87 | Thoracic kyphosis (HP:0002942) | 1.86669392 |
| 88 | Cholecystitis (HP:0001082) | 1.86628679 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 1.86628679 |
| 90 | Episodic fever (HP:0001954) | 1.86083453 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 1.83669428 |
| 92 | Hemorrhage of the eye (HP:0011885) | 1.83339237 |
| 93 | Emphysema (HP:0002097) | 1.83294971 |
| 94 | Osteomyelitis (HP:0002754) | 1.82410290 |
| 95 | Hemoptysis (HP:0002105) | 1.80226190 |
| 96 | Restrictive lung disease (HP:0002091) | 1.78832833 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.78541364 |
| 98 | Polygenic inheritance (HP:0010982) | 1.78286765 |
| 99 | Gingival bleeding (HP:0000225) | 1.76766802 |
| 100 | Rhabdomyolysis (HP:0003201) | 1.75739020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.79058714 |
| 2 | RIPK4 | 3.45752444 |
| 3 | NME2 | 3.27650108 |
| 4 | MAP4K1 | 3.25701403 |
| 5 | TRIB3 | 2.83754360 |
| 6 | PRPF4B | 2.68651155 |
| 7 | MAP3K11 | 2.50541522 |
| 8 | MAP2K3 | 2.33289867 |
| 9 | IRAK3 | 2.26269079 |
| 10 | TYK2 | 2.00328663 |
| 11 | TBK1 | 1.95206946 |
| 12 | SIK1 | 1.93395884 |
| 13 | BLK | 1.88066038 |
| 14 | TAOK1 | 1.86817084 |
| 15 | IRAK4 | 1.86432200 |
| 16 | TAOK2 | 1.85790894 |
| 17 | MAP3K3 | 1.84241100 |
| 18 | SMG1 | 1.82457931 |
| 19 | GRK6 | 1.77445080 |
| 20 | TESK2 | 1.76583971 |
| 21 | ZAP70 | 1.69776047 |
| 22 | TNK2 | 1.65445607 |
| 23 | CSK | 1.64946422 |
| 24 | TESK1 | 1.63734200 |
| 25 | EPHB1 | 1.35639042 |
| 26 | MAP3K1 | 1.32688568 |
| 27 | TTN | 1.30907548 |
| 28 | MAP3K13 | 1.30459333 |
| 29 | FES | 1.30298709 |
| 30 | TGFBR2 | 1.26770602 |
| 31 | ARAF | 1.23777554 |
| 32 | MAP3K14 | 1.23756305 |
| 33 | JAK3 | 1.23324708 |
| 34 | BTK | 1.22388551 |
| 35 | PIM2 | 1.18596281 |
| 36 | PRKD2 | 1.14258563 |
| 37 | RIPK1 | 1.14253772 |
| 38 | IKBKE | 1.10171828 |
| 39 | IKBKB | 1.05931228 |
| 40 | SYK | 1.04528649 |
| 41 | LRRK2 | 0.99780132 |
| 42 | SIK3 | 0.93210971 |
| 43 | HCK | 0.92536756 |
| 44 | IRAK2 | 0.92057529 |
| 45 | PDPK1 | 0.89163050 |
| 46 | CSF1R | 0.89023981 |
| 47 | JAK1 | 0.86155883 |
| 48 | ICK | 0.85648831 |
| 49 | BMX | 0.83869654 |
| 50 | CDC42BPA | 0.81624081 |
| 51 | PTK6 | 0.80650601 |
| 52 | MARK2 | 0.80503556 |
| 53 | FGR | 0.80405028 |
| 54 | EPHA2 | 0.80080869 |
| 55 | KDR | 0.78912110 |
| 56 | PAK4 | 0.78323119 |
| 57 | MAPK12 | 0.78003632 |
| 58 | LYN | 0.76929891 |
| 59 | PKN2 | 0.75112323 |
| 60 | STK10 | 0.73019352 |
| 61 | ABL2 | 0.72573627 |
| 62 | MAPKAPK3 | 0.71514668 |
| 63 | MATK | 0.71489220 |
| 64 | KIT | 0.71317912 |
| 65 | MOS | 0.70800235 |
| 66 | LCK | 0.70309699 |
| 67 | EEF2K | 0.68524802 |
| 68 | PDK1 | 0.66036883 |
| 69 | HIPK2 | 0.65258959 |
| 70 | BCKDK | 0.64300696 |
| 71 | TXK | 0.63790892 |
| 72 | RPS6KL1 | 0.62665423 |
| 73 | RPS6KC1 | 0.62665423 |
| 74 | JAK2 | 0.62479062 |
| 75 | BMPR2 | 0.60061306 |
| 76 | MAPKAPK2 | 0.56607247 |
| 77 | MAP3K6 | 0.55251357 |
| 78 | RPS6KA2 | 0.54204325 |
| 79 | MARK3 | 0.52910130 |
| 80 | PRKG2 | 0.52579278 |
| 81 | KSR2 | 0.52560485 |
| 82 | FGFR4 | 0.52245099 |
| 83 | MAP3K8 | 0.51610159 |
| 84 | MAPK11 | 0.51028933 |
| 85 | BRAF | 0.48327332 |
| 86 | SIK2 | 0.47802762 |
| 87 | MAP2K2 | 0.47664230 |
| 88 | GRK7 | 0.47555459 |
| 89 | RPS6KA6 | 0.46901487 |
| 90 | MAPK4 | 0.41857822 |
| 91 | ITK | 0.40771467 |
| 92 | IRAK1 | 0.40425904 |
| 93 | ILK | 0.38055403 |
| 94 | MAP2K6 | 0.37274348 |
| 95 | DYRK1B | 0.37162883 |
| 96 | MAP3K7 | 0.36639673 |
| 97 | MAPK7 | 0.34101376 |
| 98 | CDK4 | 0.33977272 |
| 99 | DAPK3 | 0.33784256 |
| 100 | PRKCQ | 0.33634193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.09168732 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70090246 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45346884 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33611913 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.16525645 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.13960349 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99790487 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.99695654 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99546169 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94892430 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94849178 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94047984 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.88973432 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.87586210 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72306219 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69419837 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63308703 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.61648308 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60557723 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54269907 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50480939 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49811570 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48042975 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46356110 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43094836 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.42784195 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.39609832 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38872774 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37480616 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33706242 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.30565607 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27691836 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.27165799 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.26607613 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23150156 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22875646 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20523049 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20117288 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18896748 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18527598 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.17422625 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.17145662 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16405344 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15931114 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.15578295 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.15512328 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11238356 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08676821 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07424073 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.06779573 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.04107477 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02957619 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01327197 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00245343 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96250869 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.96044795 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94525622 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93626511 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93455818 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92991750 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91676486 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91164564 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.90670619 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.90192692 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89241983 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88519881 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.87826987 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83484454 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.80684122 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77739877 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.73878873 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72301962 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70461077 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.69407407 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68462038 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64589677 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64210431 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64162302 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63428394 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61595208 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61229996 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60902037 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58237472 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55121000 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51805761 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47885054 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46945697 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46025479 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44802418 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43517646 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43461361 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42148296 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40836555 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40562054 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38982330 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38780501 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35128593 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34686282 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33306997 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32916888 |

